iBio Inc (IBIO)

[7mule3]

iBio opened ten years ago with a federal grant to establish facilities capable of rapid delivery of medical countermeasures in response to a disease pandemic.

FastPharming Technology has been used to produce antibody candidates for Ebola and Dengue fever viruses, yellow fever virus, human papilloma virus, seasonal influenza and avian influenza.

The Company’s subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services via its 130,000 square foot facility in Bryan, Texas.

iBio acquired Caliber’s facility in early 2016. The building is in the Brazos Valley’s Biocorridor, which runs along the College Station!

Part of the reason the Brazos Valley was chosen to be home to the facility was the proximity to Texas A&M University, its research and its talent. In fact, a primary focus of iBio is hiring people trained locally.